Inmedix
Normandy Park, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
AJ
Andrew J Holman MDinFounder
AH
Andrew Holman, M.D.Named on SEC filing
Board
BT
Bernie TobinBoard director
KT
Kevin Tracey, M.D.Board director
SD
Steven Daly, M.S., M.B.A.Board director
RS
Ryan Sullivan, Ph.D.Board director
LH
Leroy Hood, M.D., Ph.D.Board director
Investors · 1
Competitors · 5
by search overlapTrimedx9 shared keywordsTrimedx (TMX) provides clinical engineering and asset management services for health systems, using an AI-based performance intelligence platform combined with embedded engineers, advisors, and cybersecurity analysts. Its services maintain medical device uptime, inform capital and lifecycle decisions, and secure connected devices across hospital operations.
Augmedix Exits false7 shared keywordsAugmedix provides ambient AI that captures exam-room conversations and generates medical notes, handling EHR documentation for clinicians. It serves health systems, hospitals, and clinics with products tailored to specialties such as emergency medicine and oncology.
InfraReDx7 shared keywordsInfraredx develops intravascular imaging technology combining near-infrared spectroscopy (NIRS) and intravascular ultrasound (IVUS) to map coronary artery disease for interventional cardiologists. As a Nipro company, it is part of a broader portfolio of interventional cardiology and peripheral vascular products including PTCA and PTA balloons.
Genomeweb6 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Imvax6 shared keywordsImvax is a clinical-stage biopharmaceutical company developing personalized immunotherapies aimed at treating solid tumors, including glioblastoma. Its platform draws on autologous, cell-based approaches to target cancer.
Companies competing with Inmedix for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 5 rounds · 2021–2025
▶$160KraisedOct 2025 · 4 investors · BiotechnologyRule 506(c)
▶$160KraisedOct 2025 · 4 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Bernie TobinDirector
- Andrew Holman, M.D.Executive Officer, Director
- Steven Daly, M.S., M.B.A.Director
- Leroy Hood, M.D., Ph.D.Director
- Kevin Tracey, M.D.Director
- Ryan Sullivan, Ph.D.Director
- Offering amount
- $5M
- Amount sold
- $160K
- Minimum investment
- $50K
- Proceeds to insiders
- $120K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$720KraisedNov 2024 · 5 investors · BiotechnologyRule 506(c)
▶$720KraisedNov 2024 · 5 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Bernie TobinDirector
- Kevin Tracey, M.D.Director
- Steven Daly, M.S., M.B.A.Director
- Ryan Sullivan, Ph.D.Director
- Leroy Hood, M.D., Ph.D.Director
- Andrew Holman, M.D.Executive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $720K
- Minimum investment
- $20K
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$25KraisedApr 2023 · BiotechnologyRule 506(c)
▶$25KraisedApr 2023 · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Leroy Hood, M.D., Ph.D.Director
- Kevin Tracey, M.D.Director
- Steven Daly, M.S., M.B.A.Director
- Andrew Holman, M.D.Executive Officer, Director
- Bernie TobinDirector
- Offering amount
- $3M
- Amount sold
- $25K
- Minimum investment
- $25K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$445KraisedMar 2022 · 6 investors · Other Health CareRule 506(b)
▶$445KraisedMar 2022 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven J. DalyDirector
- Andrew J HolmanExecutive Officer, Director
- Bernie TobinDirector
- Offering amount
- $3M
- Amount sold
- $445K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$470KraisedMar 2021 · 8 investors · Other Health CareRule 506(b)
▶$470KraisedMar 2021 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven DalyDirector
- Bernie TobinDirector
- Andrew J. HolmanExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $470K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Inmedix?
- Inmedix was founded by Andrew J Holman MD.
- Who are Inmedix's investors?
- Inmedix's investors include Keiretsu Forum.
- How much funding has Inmedix raised?
- Inmedix has disclosed $1.8M raised across 5 rounds.
- Where is Inmedix headquartered?
- Inmedix is headquartered in Normandy Park, US.